Richter Gedeon Nyrt.

Richter Gedeon Nyrt., founded in Hungary in 1901, is a leading pharmaceutical company with a broad spectrum in drug development, manufacture, market, and sales. Known for its strong innovation capabilities, the company primarily focuses on female healthcare, the central nervous system, and cardiovascular treatment. Richter Gedeon Nyrt. has a significant footprint in both Europe and globally, with a strategic emphasis on research and development to provide generic solutions alongside patented products. Its role in the pharmaceutical industry is pivotal as it advances healthcare solutions tailored to precise therapeutic needs. The company also enhances its offerings through strategic partnerships and acquisitions, continuously expanding its portfolio and market reach. As one of Hungary’s most prominent corporations, it is a key player on the Budapest Stock Exchange, representing a vital component of the BUX Index. Through its robust R&D wing, Richter Gedeon contributes significantly to Hungary's biotechnology sector, underscoring its role as an agent of innovation and a driver of significant scientific advancements in global healthcare.